MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram Read more about MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram
Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults Read more about Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults
Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection Read more about Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer Read more about Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures Read more about Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma Read more about HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder Read more about Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Read more about Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis Read more about Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis